Diploma (LON:DPLM) Given New GBX 7,500 Price Target at Berenberg Bank

Diploma (LON:DPLM) had its price objective raised by Berenberg Bank from GBX 6,600 to GBX 7,500 in a research report sent to investors on Thursday, MarketBeat reports. They currently have a buy rating on the stock.

Several other analysts have also weighed in on the stock. Shore Capital Group reiterated a “hold” rating on shares of Diploma in a research note on Wednesday. Peel Hunt restated a “buy” rating and issued a GBX 6,150 price target on shares of Diploma in a report on Friday, December 19th. Stifel Nicolaus raised their price target on shares of Diploma from GBX 6,200 to GBX 6,800 and gave the stock a “buy” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Diploma from GBX 6,200 to GBX 6,400 and gave the company a “buy” rating in a research note on Thursday. Finally, Royal Bank Of Canada upped their price objective on shares of Diploma from GBX 6,200 to GBX 6,600 and gave the company an “outperform” rating in a report on Thursday. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Diploma has an average rating of “Moderate Buy” and a consensus price target of GBX 6,023.75.

Diploma Price Performance

Diploma stock opened at GBX 5,795 on Thursday. The stock has a market capitalization of £7.77 billion, a price-to-earnings ratio of 42.21, a PEG ratio of 2.82 and a beta of 1.03. Diploma has a 52-week low of GBX 3,532 and a 52-week high of GBX 6,019.52. The stock’s 50 day moving average price is GBX 5,456.45 and its two-hundred day moving average price is GBX 5,423.86. The company has a debt-to-equity ratio of 46.97, a quick ratio of 0.80 and a current ratio of 2.04.

Insider Transactions at Diploma

In other news, insider Ian El-Mokadem bought 500 shares of the business’s stock in a transaction that occurred on Wednesday, January 14th. The shares were bought at an average cost of GBX 5,615 per share, for a total transaction of £28,075. Also, insider Johnny Thomson sold 30,000 shares of the stock in a transaction on Friday, January 16th. The stock was sold at an average price of GBX 5,668, for a total value of £1,700,400. 1.14% of the stock is owned by insiders.

Trending Headlines about Diploma

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Diploma upgraded full‑year guidance after a stronger‑than‑expected first half, citing resilient aerospace demand — this is the catalyst that drove the recent rally. Article Title Article Title
• Positive Sentiment: Berenberg raised its price target to GBX 7,500 and moved to a “buy” rating, signaling stronger analyst conviction. Article Title
• Positive Sentiment: Stifel Nicolaus lifted its target to GBX 6,800 and reiterated a “buy” stance, reflecting upgraded earnings assumptions. Article Title
• Positive Sentiment: RBC increased its target to GBX 6,600 and moved to “outperform” after Diploma’s guidance upgrade; coverage note posted to LSE and TickerReport. Article Title Article Title
• Positive Sentiment: Deutsche Bank raised its target to GBX 6,400 and set a “buy” rating, further supporting the upgraded consensus view. Article Title
• Neutral Sentiment: Shore Capital reaffirmed a “hold” rating — a reminder some brokers remain cautious despite upgrades. Article Title Article Title
• Neutral Sentiment: Valuation sits elevated after the rally (P/E ~42, PEG ~2.8) and the stock is near its 1‑year high — this raises the bar for further upside absent continued operational beats.
• Negative Sentiment: Despite the positive fundamentals and multiple target lifts, the stock is pulling back mid‑day on very heavy volume — likely short‑term profit‑taking and consolidation after the recent surge.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.